aps 2012 meeting tailoring eln workflows to the variations ... · bioequivalence study inspections...
TRANSCRIPT
APS 2012 Meeting
Tailoring ELN Workflows to the Variations in
Regulatory Requirements for Contracted
Studies Ron Shoup, April Pisek, Jessica White, Brian Beato
Historical Background on AITB’s
ELN Implementation
4Q 2009 Completed evaluation of 3 ELN products, purchased IDBS E-Workbook
1Q 2010 Extensive initial training; wrote user requirements for approximately 20 workflows to create templates
2Q-3Q 2010 Template creation, administrative operations decisions
4Q 2010 Validation of templates and hierarchy
2Q 2012 Over 60 templates now validated
ELN’s aren’t “Lab in a Box”
• IDBS E-Workbook Suite A powerful platform of infinite possibilities (especially if you have
infinite patience and resources!)
Similar to a pile of Legos (what do you wish to build?)
Many ELN implementations remain underutilized due to complexity.
• Certainly can use a product quickly as a
“post-it” lab notebook, which offers search
functionality, common access to information,
organization of data.
• But enforcing workflows using forms and
building validated resources to automate
calculations was more valuable to us.
How Far to Develop?
Integrating Disparate Workflows into a
Single System
Mgmt. Functions (3)
Metrology Activities (5)
Reagents,
Standards,
Materials (9)
Method Validation (10)
Training (2)
Study Conduct (8)
Sample Analysis (2)
Quality Assurance (3)
Study
Report
Writing (2)
LBA (12)
Numerous Tools Customized
Tabulation
and Analysis
Hooks to
Watson LIMS
• Unstructured option, like a paper notebook
• Validated templates for repetitive tasks
– Business & scientific rules enforced
– Error prevention in real time
• Hierarchy organizes & segregates information and data
• Role-based permissions to create, add to, change records
• Records immediately viewable by all permitted
• Secure links to other databases such as Watson LIMS
Implementation Features
Electronic forms deliver on expectations:
A blessing and a curse….
We created a fully validated system with pivotal
bioequivalence study inspections in mind…BUT did we
overbuild?
Ex: How do we perform discovery studies when
compounds are uncharacterized?
“Audit by exception” was too tightly wound!
Receive reference standard
Create calibration and QC samples
Make stock and spiking solutions
Perform method validation run (first of many)
Day 1 Day 2
Solutions expired by
default
QC samples expired by
default
Subsequent method validation runs
blocked
• List the labels and fields for each variation of
the desired template.
• Determine whether an entry is required and
how to check the response.
• Create flowchart to organize the business
logic to be implemented.
• Review field checks and mandatory entries
before allowing the experiment data to be
published.
Building Templates to Mimic
Workflows
Fewer mandatory entries for experiment completion:
“Field checks” are conditional to allow nonregulated activity:
Strategy:
• Use a Study Summary experiment to declare
general information about the project.
• Use the Study Summary declarations when
executing the business logic behind
experiments related to the study.
• Use the information to allow or disallow
supporting experiments.
Study Type?
Establish Method
Sample Analysis
PI creates Study
Summary experiment:
Perform experiments
as required to
establish the method
Templates created for:
Standards, solutions,
extraction method,
instrument analysis…
Method
Development
Method
Validation
Long Term
Stability
Sample
Analysis
Study Type? Sample Analysis
PI declares in Study
Summary experiment:
method/version,
regulatory status
Perform Sample Prep and
Instrumental Analysis experiments as
required to assay the samples
Regulated? No
unregulated assets
can be involved in
study
Non-regulated?
Either type of asset
can be involved in
study
Establish Method
• Consider workflow variations as function of
regulatory requirements.
• Test forms on paper
• Create templates with correct business logic,
mandatory entries, and field checks
• Control use of templates by hierarchy
relationships
Design Strategy Summary
• Switchable between different levels of
regulatory scrutiny
• Can use the same templates for R&D,
validation, sample analysis
• Discovery data can be segregated to prevent
misinterpretation as part of the final report
• All remains searchable
• All calculations, equipment notes, and other
details remain accurate
Advantages of Multidimensional
Templates